首页 Arrowhead制药(usARWR)-基本信息

Arrowhead制药(usARWR)-基本信息

日报更新时间:04-17 11:30

周报更新时间:04-18 04:06

行情信息

今开价:68.49

最高价:69.47

成交量:636217.0

昨收价:67.98

最低价:67.23

最新价:67.65

行情图标
概要信息

中文名称:Arrowhead制药


英文名称:Arrowhead Pharmaceuticals


行业:服务业


简介:Arrowhead Pharmaceuticals, Inc.是一家临床阶段的有针对性的治疗公司,在肿瘤、肥胖以及慢性乙肝病毒感染方面有发展计划


电话:1-626-3043400


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

Arrowhead Pharmaceuticals公司利用其专有的Dynamic Polyconjugate平台,开发基于RNA干扰机制沉默致病基因的靶向药物。公司候选产品包括:一、临床阶段产品 ARC-520,一种基于RNAi的疗法,用于治疗慢性乙型肝炎病毒感染,目前处于IIb期临床试验阶段; ARC-AAT,一种含有基于RNAi的治疗剂的新型解锁核碱基类似物,用于治疗与α-1抗胰蛋白酶缺乏相关的肝病,目前处于Ib期临床试验中。二、临床前产品 ARC-521,一种用于治疗慢性乙型肝炎病毒的基于RNAi的治疗剂; ARC-F12,基于RNAi的治疗遗传性血管性水肿和血栓栓塞性疾病的治疗剂; ARC-HIF2,基于RNAi的治疗肾细胞癌的治疗剂; ARC-LPA,基于RNAi的治疗心血管疾病的治疗剂。此外,Arrowhead Pharmaceuticals还拥有与用于治疗肥胖症和相关代谢疾病的Adipotide有关的专利。Arrowhead Pharmaceuticals公司与Shire AG开展研究合作和许可协议,开发和商业化靶向肽 - 药物偶联物(targeted peptide-drug conjugates);与Spring Bank Pharmaceuticals,Inc.合作开展Arrowhead的ARC-520和Spring Bank的SB 9200治疗慢性乙型肝炎的研究。

交易日期 交易人 职位 类型 交易份额 价格
2019-06-25 Ferrari (Mauro) Director Sell 17756 27.61
2019-05-30 Myszkowski (Kenneth Allen) Chief Financial Officer Buy 20000 5.19
2019-05-30 Myszkowski (Kenneth Allen) Chief Financial Officer Buy 15000 4.60
2019-05-27 O'Brien (Patrick C) General Counsel Sell 30000 24.88
2019-05-23 Anzalone (Christopher Richard) Chief Executive Officer Buy 9376 2.62
2019-05-23 Anzalone (Christopher Richard) Chief Executive Officer Buy 40072 2.01
2019-05-20 Myszkowski (Kenneth Allen) Chief Financial Officer Sell 27071 22.00
2019-04-02 Anzalone (Christopher Richard) Chief Executive Officer Sell 50000 19.30
2019-02-28 Given (Bruce D) Chief Operating Officer Buy 42500 2.01
2019-02-28 Given (Bruce D) Chief Operating Officer Sell 42500 19.99
2019-02-25 Given (Douglass Bruce M.D., Ph.D Director Buy 18000 2.19
2019-02-25 Given (Douglass Bruce M.D., Ph.D Director Buy 30000 5.19
2019-02-25 Given (Douglass Bruce M.D., Ph.D Director Sell 65000 19.25
2019-02-25 Given (Douglass Bruce M.D., Ph.D Director Buy 7000 4.75
2019-02-25 Given (Douglass Bruce M.D., Ph.D Director Buy 10000 2.62
2019-02-24 Given (Bruce D) Chief Operating Officer Buy 42500 2.01
2019-02-24 Given (Bruce D) Chief Operating Officer Sell 42500 18.98
2019-02-21 Given (Douglass Bruce M.D., Ph.D Director Sell 3000 18.05
2019-02-18 Myszkowski (Kenneth Allen) Chief Financial Officer Buy 8000 5.20
2019-02-18 Myszkowski (Kenneth Allen) Chief Financial Officer Sell 8000 18.00
2019-02-18 Given (Bruce D) Chief Operating Officer Sell 42500 17.98
2019-02-18 Given (Bruce D) Chief Operating Officer Buy 42500 2.01
2019-02-14 Given (Bruce D) Chief Operating Officer Sell 26250 17.67
2019-02-11 Given (Bruce D) Chief Operating Officer Buy 42500 2.01
2019-02-11 Given (Bruce D) Chief Operating Officer Sell 42500 17.06

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Northern Trust Corp 1196067 1.26% 107755 9.90% 2019-03-31
SSGA Funds Management Inc 2744945 2.88% 30930 1.14% 2019-07-31
Invesco Ltd (OFI / OppenheimerFunds) 4000000 4.20% -1800000 -31.03% 2019-07-31
State Street Corporation 4704597 4.96% -369178 -7.28% 2019-03-31
First Manhattan Company 4923525 5.19% -103600 -2.06% 2019-03-31
Vanguard Group Inc 4925446 5.19% 852728 20.94% 2019-03-31
BlackRock Inc 7631074 8.05% 446453 6.21% 2019-03-31
OppenheimerFunds Inc 7803131 8.23% -2951 -0.04% 2019-03-31
BlackRock Fund Advisors 11131463 11.69% -211409 -1.86% 2019-07-31
Vanguard Investments Australia Ltd 2357160 2.48% 330 0.01% 2019-07-31
Vivo Capital, LLC 2328475 2.46% -- -- 2019-03-31
Farallon Capital Management, L.L.C. 1920609 2.03% 420609 28.04% 2019-03-31
Goldman Sachs Group Inc 1248091 1.32% -47893 -3.70% 2019-03-31
Adage Capital Partners Gp LLC 1375000 1.45% -- -- 2019-03-31
Fidelity SelectCo, LLC 1387414 1.46% -236700 -14.57% 2019-07-31
RTW INVESTMENTS, LLC 1528213 1.61% -3787943 -71.25% 2019-03-31
Fiera Capital Corporation 1555255 1.64% -22516 -1.43% 2019-03-31
Fidelity Management and Research Company 1712539 1.81% -20306 -1.17% 2019-03-31
FMR Inc 1712539 1.81% -20306 -1.17% 2019-03-31
Northern Trust Investments Inc 1858553 1.95% 43376 2.39% 2019-07-31
Invesco Capital Management LLC 1294682 1.37% -389624 -23.13% 2019-05-31
Geode Capital Management, LLC 1992916 2.10% 1070753 116.11% 2018-12-31
BlackRock Asset Management Canada Ltd 13322590 14.05% 5592529 72.35% 2019-05-31
OFI Global Asset Management, Inc. 7800000 8.24% -- -- 2019-04-30
Northern Trust Investments N A 1088312 1.16% -20952 -1.89% 2018-12-31
Fidelity Management & Research Company 912218 0.97% 29304 3.32% 2019-01-31
Amvescap Plc. 1194214 1.27% 209251 21.24% 2018-09-30
BlackRock Institutional Trust Company NA 2515294 2.86% 969251 62.69% 2018-06-30
Millennium Management LLC 817317 0.93% -199110 -19.59% 2018-03-31
Silence Therapeutics PLC 2790202 3.73% -2005111 -41.81% 2017-12-08
Ghost Tree Capital, LLC 700000 0.80% -100000 -12.50% 2018-06-30
Citadel Advisors Llc 600994 0.68% 575955 2300.23% 2018-06-30
Charles Schwab Investment Management Inc 457891 0.52% 184849 67.70% 2018-06-30
venBio Select Advisor LLC 450000 0.51% 450000 -- 2018-06-30
Novartis AG 3321383 4.65% 3321383 -- 2017-11-28
Invesco PowerShares Capital Mgmt LLC 984963 1.12% 984963 -- 2018-06-30
Longwood Capital Partners LLC 1030330 1.17% -731876 -41.53% 2018-06-30
State Street Corp 4031856 4.59% 1478425 57.90% 2018-06-30
Perceptive Advisors LLC 365445 0.42% -- -- 2018-06-30
D. E. Shaw & Co LP 891784 1.02% -276095 -23.64% 2018-03-31
Goldman, Sachs & Co. 542726 0.62% 369648 213.57% 2018-03-31
Teachers Advisors Inc 357475 0.41% 357475 -- 2018-06-30
NEXTHERA CAPITAL LP 1114097 1.27% 1114097 -- 2018-03-31
PDT Partners, LLC 459400 0.52% 124200 37.05% 2018-03-31
BlueCrest Capital Management Ltd. 246490 0.28% 171882 230.38% 2018-03-31
Susquehanna International Group, LLP 244065 0.28% 87317 55.71% 2018-03-31
Allianz Global Investors 462105 0.62% 9985 2.21% 2017-12-31
Morgan Stanley & Co Inc 247718 0.33% 246646 23008.02% 2017-12-31
J.P. Morgan Securities Inc 247380 0.33% 247380 -- 2017-12-31
Voya Investments, LLC 240000 0.32% -568229 -70.31% 2017-12-31
Alps Advisors Inc 116402 0.13% 33546 40.49% 2018-03-31
Bridgeway Capital Management, Inc 219200 0.29% 19200 9.60% 2017-12-31
Vassalluzzo Scott J 203270 0.27% -29200 -12.56% 2017-12-31
California Public Employees Retrmnt Sys 234500 0.31% -- -- 2017-09-30
Marshall Wace North America LP 106281 0.14% 106281 -- 2017-09-30
Numeric Investors LLC 138800 0.19% 138800 -- 2017-12-31
Allianz Global Inv Fund Mgmt LLC 154465 0.21% 7605 5.18% 2017-12-31
Element Capital Management LLC 142649 0.19% -151235 -51.46% 2017-09-30
AST Investment Services Inc 272335 0.36% 18900 7.46% 2017-12-31
First Allied Advisory Services Inc 61000 0.08% -- -- 2017-09-30
Susquehanna Financial Group, LLLP 303997 0.41% 126994 71.75% 2017-06-30
Renaissance Technologies Corp 374164 0.50% 374164 -- 2017-06-30
Qvt Financial LP 2556256 3.66% 508474 24.83% 2016-09-30
Columbia Mangmt Investment Advisers, LLC 506565 0.73% -184230 -26.67% 2016-09-30
Hillhouse Capital Management, Ltd. 677966 0.97% 677966 -- 2016-09-30
J.P. Morgan Investment Management Inc 1197927 1.72% 2955 0.25% 2016-09-30
RA Capital Management, LLC 1525424 2.19% 1525424 -- 2016-09-30
Baker Bros Advisors LP 1856967 2.66% 847458 83.95% 2016-09-30
Orbimed Advisors, LLC 2159973 3.10% 2159973 -- 2016-09-30
BlackRock Advisors LLC 240176 0.34% 8464 3.65% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Vanguard Extended Market Index Fund 1307244 1.37% 4421 0.34% 2019-06-30
iShares Core S&P Small-Cap ETF 5719590 6.01% 5500 0.10% 2019-07-30
Invesco Oppenheimer Global Opports Fund 4000000 4.20% -1800000 -31.03% 2019-06-30
Vanguard Total Stock Market Index Fund 2337709 2.46% 443 0.02% 2019-06-30
iShares Russell 2000 ETF 2054306 2.16% 20994 1.03% 2019-07-30
iShares S&P Small-Cap 600 Growth ETF 1378318 1.45% -- -- 2019-07-30
Vanguard Small Cap Index 1086759 1.14% 1086759 -- 2019-06-30
iShares Nasdaq Biotechnology ETF 935965 0.98% 9728 1.05% 2019-07-30
iShares Russell 2000 Growth ETF 856306 0.90% 9989 1.18% 2019-07-30
Vanguard Tax Managed Small Cap Fund 795098 0.84% 465125 140.96% 2019-06-30
SPDR 505816 0.53% -- -- 2019-07-31
Columbia Small Cap Index Fund 510020 0.54% -4390 -0.85% 2019-06-30
Invesco S&P SmallCap Health Care ETF 510761 0.54% -12162 -2.33% 2019-07-31
Candriam Eqs L Biotechnology 529000 0.56% -65000 -10.94% 2019-06-30
Apex SMID Growth-UBS 557147 0.59% -57394 -9.34% 2019-06-30
Principal SmallCap S&P 600 Idx SP 597206 0.63% 4665 0.79% 2019-06-30
Vanguard Small Cap Growth Index Fund 625399 0.66% 625399 -- 2019-06-30
Fidelity 459433 0.48% -8672 -1.85% 2019-06-30
HBM Healthcare Investments AG 550000 0.58% 50000 10.00% 2019-03-31
State Street Russell Small Cap 401195 0.42% -- -- 2019-06-30
State Street Russell Small/Mid Cap 402471 0.42% -- -- 2019-06-30
NT R2000 Growth Index Fund - Non-Lending 406288 0.43% 33786 9.07% 2019-03-31
iShares US Small Cap ETF (CAD-Hedged) 1911263 2.02% -3204 -0.17% 2019-05-30
iShares Core S&P US Total Market ETF 5648448 5.96% -- -- 2019-05-30
iShares Core MSCI AllCntry Wld exCan ETF 5649450 5.96% 5593790 10049.93% 2019-05-23
Oppenheimer Global Opportunities Fund 7800000 8.24% -- -- 2019-03-31
Invesco Dynamic Biotech & Genome ETF 382807 0.40% -- -- 2019-04-30
NT R2000 Index Fund - NL 355973 0.38% 30581 9.40% 2019-03-31
Direxion Daily S&P Biotech Bull 3X Shrs 280176 0.30% 76026 37.24% 2019-04-30
NT R2000 Growth Index Fund - Lending 277673 0.29% 21910 8.57% 2019-03-31
Schwab US Small-Cap ETF 276198 0.29% -- -- 2019-04-30
Northern Trust Russell 2000 Index DC NL 241099 0.26% 17586 7.87% 2019-03-31
Invesco DWA SmallCap Momentum ETF 248138 0.26% -- -- 2019-03-31
iShares Micro-Cap ETF 222356 0.24% 973 0.44% 2019-03-29
Vanguard Health Care Index Fund 210750 0.22% 8178 4.04% 2019-02-28
Schwab Small Cap Index Fund 169973 0.18% -- -- 2019-01-31
Baron Opportunity Fund 162000 0.17% 162000 -- 2018-12-31
The Vanguard - Russell 2000 Grwth Idx CF 154471 0.16% -- -- 2019-01-31
AXA 2000 Managed Volatility Portfolio 140990 0.15% 4906 3.61% 2018-12-31
Fidelity Advisor 336700 0.37% -3300 -0.97% 2018-11-30
Invesco DWA Healthcare Momentum ETF 330908 0.36% -- -- 2018-12-31
Oak Ridge Small Cap Growth Fund 158000 0.17% 158000 -- 2018-08-31
Bridgeway Ultra Small Company Market Fd 200000 0.23% -- -- 2018-03-31
AST RCM World Trends Portfolio 272335 0.31% 18900 7.46% 2017-12-31
AXA 2000 Managed Volatility K 131832 0.15% -- -- 2018-07-31
BlackRock Extended Equity Market K 149722 0.17% 50333 50.64% 2018-06-30
The Vanguard Russell 2000 Growth Index 156572 0.18% 2564 1.66% 2018-07-31
Schwab Small Cap Index 162200 0.18% -- -- 2018-07-31
Vanguard Health Care ETF 171366 0.20% 1458 0.86% 2018-07-31
Oppenheimer Global Opportunities A 7800000 8.88% -- -- 2018-07-31
Vanguard Total Stock Mkt Idx 1959942 2.23% -- -- 2018-07-31
iShares Nasdaq Biotechnology 992101 1.46% -1890 -0.19% 2018-09-12
Vanguard Extended Market Idx Inv 1157075 1.32% 11532 1.01% 2018-07-31
iShares Russell 2000 Growth 832100 1.23% -802 -0.10% 2018-09-12
PowerShares DWA Healthcare Momentum ETF 530605 0.75% -- -- 2018-09-13
PowerShares DWA SmallCap Momentum ETF 375390 0.53% -- -- 2018-09-13
iShares Micro-Cap 233274 0.34% -- -- 2018-09-12
Northern Trust Russell 2000 Index Fund - DC - Non-Lending 212839 0.24% -560 -0.26% 2018-07-31
Fidelity Spartan 177530 0.20% -- -- 2018-07-31
PowerShares Dynamic Biotech & Genome ETF 835882 0.91% -- -- 2018-09-05
CREF Stock R1 131974 0.15% 131974 -- 2018-06-30
BlackRock Russell 2000 127895 0.15% 127895 -- 2018-06-30
Vanguard Instl Ttl Stk Mkt Idx InstlPls 120272 0.14% -- -- 2018-06-30
BioShares 68587 0.09% -- -- 2018-07-13
Bridgeway Ultra-Small Company Market 200000 0.23% -- -- 2018-03-31
BlackRock Russell 2500 119814 0.14% 119814 -- 2018-06-30
Vanguard Balanced Index Inv 62819 0.07% -- -- 2018-05-31
iShares Core S&P Total US Stock Mkt 42484 0.06% 72 0.17% 2018-06-28
Schwab US Broad Market ETF 31872 0.04% -- -- 2018-06-21
ProShares Ultra Nasdaq Biotechnology 37905 0.04% -419 -1.09% 2018-05-31
ALPS Medical Breakthroughs ETF 131105 0.14% 2262 1.76% 2018-06-08
BNY Mellon EB DL Mkt Completion 52765 0.06% -- -- 2018-03-31
BlackRock U.S. Equity Market F 45778 0.05% 4853 11.86% 2018-03-31
T. Rowe Price Extended Equity Market Idx 37900 0.04% -- -- 2018-03-31
AllianzGI Small-Cap Blend A 154465 0.21% 7605 5.18% 2017-12-31
AST RCM World Trends 272335 0.36% 18900 7.46% 2017-12-31
BNY Mellon Market Completion Fund UC1 52765 0.07% 49486 1509.18% 2017-09-30
Vericimetry U.S. Small Cap Value 27700 0.04% 27700 -- 2017-09-30
JPMorgan US Small Company Instl 358700 0.48% 8900 2.54% 2016-12-31
Columbia VP US Equities 2 321585 0.43% -- -- 2016-12-31
JNL/Mellon Capital Healthcare Sector B 56424 0.08% -- -- 2016-09-30
Russell Small Cap Fund Class B 73356 0.12% 73356 -- 2016-06-30
Columbia Small Cap Core Z 133645 0.18% -- -- 2016-12-31
Metropolitan Ser Russell 2000 Index B 25887 -- -- -- 2016-09-30
iShares Russell 2000 (AU) 954208 1.70% -1206 -0.10% 2015-11-19
JPMorgan Small Cap Growth 534385 0.90% 2264 0.40% 2015-09-30
Columbia VP US Equities Fund 410510 0.70% -- -- 2015-09-30
JPMorgan US Small Company Fund 351800 0.60% 1100 0.30% 2015-09-30
Vanguard Instl Total Stock Market Index 224742 0.40% -- -- 2015-10-31
JPMorgan Dynamic Small Cap Growth Fund 205370 0.40% -- -- 2015-09-30
iShares Russell 2000 Value 182248 0.30% -- -- 2015-11-19
SSgA Russell Small/Mid Cap Index Fund Tr 174700 0.30% -- -- 2015-06-30
Columbia Small Cap Growth I Fund 162900 0.30% 14800 10.00% 2015-09-30
CREF Stock Account 146813 0.20% -24659 -14.40% 2015-09-30
Oppenheimer Global Opportunities 3000000 5.00% -- -- 2015-09-30
Fidelity Spartan® Extended Mkt Indx Fd 213627 0.40% -- -- 2015-09-30

Roger David Kornberg Dr. Roger David Kornberg is Chief Scientific Officer at Cocrystal Pharma, Inc., Chairman at Cognos Therapeutics, Inc., Chairman at Sensor-Kinesis Corp., a Member at American Academy of Arts & Sciences, a Member at National Academy of Sciences and a Professor at Stanford University School of Medicine. He is on the Board of Directors at Arrowhead Pharmaceuticals, Inc., Gamida Cell Ltd. and Xenetic Biosciences, Inc. Dr. Kornberg was previously employed as Director & Chief Scientist by BioZone Pharmaceuticals, Inc., an Independent Director by OphthaliX, Inc., an Independent Director by Protalix Biotherapeutics, Inc., Director & Chief Scientist by Cocrystal Discovery, Inc., and a Professor by Harvard Medical School. He also served on the board at Teva Pharmaceutical Industries Ltd. He received his undergraduate degree from Harvard University and a doctorate degree from Stanford University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐